---
figid: PMC4343072__12964_2015_92_Fig6_HTML
figtitle: Consequences of mutant BRAF V600E in LCH
organisms:
- Human gammaherpesvirus 4
- Vesicular stomatitis virus
- Merkel cell polyomavirus
- Mycobacterium tuberculosis variant bovis BCG
- Mycobacterium tuberculosis variant bovis
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Oryctolagus cuniculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Oryctolagus cuniculus
- Danio rerio
pmcid: PMC4343072
filename: 12964_2015_92_Fig6_HTML.jpg
figlink: /pmc/articles/PMC4343072/figure/Fig6/
number: F6
caption: 'Potential consequences of mutant BRAF V600E in LCH. In mutant monocytes
  or mutant LC precursors, the constitutively active BRAF V600E mutant protein is
  predicted to bypass the requirement for mitogen-induced activation of RAF by RAS.
  The identification of activating BRAF mutations supports the hypothesis that LCH
  is a neoplastic process (oncogenic potential). However, phosphorylated ERK is rapidly
  dephosphorylated by DUSP6, which is constitutively expressed in LCH cells (GSE16395).
  Other factors, such as accumulated gene mutations and an inflammatory trigger of
  the RAS/RAF/MEK/ERK signaling pathway, thus appear to be involved in LCH pathogenesis.
  DUSP6: dual specificity phosphatase 6.'
papertitle: Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.
reftext: Ichiro Murakami, et al. Cell Commun Signal. 2015;13:13.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9670548
figid_alias: PMC4343072__F6
figtype: Figure
redirect_from: /figures/PMC4343072__F6
ndex: 402ef2b7-deca-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4343072__12964_2015_92_Fig6_HTML.html
  '@type': Dataset
  description: 'Potential consequences of mutant BRAF V600E in LCH. In mutant monocytes
    or mutant LC precursors, the constitutively active BRAF V600E mutant protein is
    predicted to bypass the requirement for mitogen-induced activation of RAF by RAS.
    The identification of activating BRAF mutations supports the hypothesis that LCH
    is a neoplastic process (oncogenic potential). However, phosphorylated ERK is
    rapidly dephosphorylated by DUSP6, which is constitutively expressed in LCH cells
    (GSE16395). Other factors, such as accumulated gene mutations and an inflammatory
    trigger of the RAS/RAF/MEK/ERK signaling pathway, thus appear to be involved in
    LCH pathogenesis. DUSP6: dual specificity phosphatase 6.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Braf
  - Braf-rs1
  - Rapgef5
  - Myd88
  - Ephb2
  - Mapk1
  - Dusp6
  - Araf
  - Mdk
  - ras
  - Hras
  - Kras
  - Rem1
  - Raf1
  - Eif2ak3
  - Lamp1
  - Tol1
  - BRAF
  - IL1R1
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - RAPGEF5
  - MYD88
  - EPHB2
  - MAPK1
  - MAPK3
  - DUSP6
  - ARAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - RAF1
  - EIF2AK3
  - braf
  - si:dkey-222f8.3
  - il1rl1
  - myd88
  - dusp6
  - araf
  - rab1ab
  - raf1a
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
